Immunogenicity of purified glycoprotein gB of herpes simplex virus

scientific article

Immunogenicity of purified glycoprotein gB of herpes simplex virus is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1000339685
P356DOI10.1007/BF01309880
P698PubMed publication ID3013134

P2093author name stringK Nishiyama
R Mori
T Eto
N Ohtomo
Y Kino
P2860cites workParticipation of three major glycoprotein antigens of herpes simplex virus type 1 early in the infectious cycle as determined by antibody-dependent cell-mediated cytotoxicity.Q33901808
Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected miceQ33906859
Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infectionQ34123889
THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAININGQ36266931
Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2Q36333640
Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infectionQ36335255
Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.Q36431330
Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivityQ36495307
Herpes Simplex Virus Glycoprotein gA/B: Evidence that the Infected Vero Cell Products Comap and Arise by ProteolysisQ36925000
Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2.Q37099580
Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cellsQ37500512
Herpes Simplex Virus Glycoproteins: Participation of Individual Herpes Simplex Virus Type 1 Glycoprotein Antigens in Immunocytolysis and Their Correlation with Previously Identified GlycopolypeptidesQ37601617
Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2Q39458271
Defective in vitro lymphoproliferative responses to herpes simplex virus in patients with frequently recurring herpes infections during the disease-free intervalQ40182907
Preparation and efficacy of an inactivated subunit vaccine (NFUI BHK) against type 2Herpes simplex virus infectionQ40191228
Mechanism of Acquired Resistance to Herpes Simplex Virus Infection as Studied in Nude MiceQ40286224
Type-common and type-specific monoclonal antibody to herpes simplex virus type 1Q41179042
Difference in age distribution of antibody to herpes simplex virus in Fukuoka, Manila and BusanQ43323079
Enhanced HSV Recovery from Neuronal Tissues of Latently Infected RabbitQ43797420
The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunityQ45793505
An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein DQ45798863
Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless miceQ45801958
Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein.Q45804968
Depression of acquired resistance against herpes simplex virus infection in neonatally thymectomized miceQ45811007
Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virusQ45838593
Immune response to a DNA free herpes simplex vaccine in manQ72956055
P433issue1-4
P1104number of pages12
P304page(s)69-80
P577publication date1986-01-01
P1433published inArchives of VirologyQ2860564
P1476titleImmunogenicity of purified glycoprotein gB of herpes simplex virus
P478volume89

Reverse relations

cites work (P2860)
Q36527580Developments in herpes simplex virus vaccines: old problems and new challenges
Q45850884Escherichia coli-derived envelope protein gD but not gC antigens of herpes simplex virus protect mice against a lethal challenge with HSV-1 and HSV-2.
Q36884382Expression of cell-associated and secreted forms of herpes simplex virus type 1 glycoprotein gB in mammalian cells
Q34340404Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection
Q36626491Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.
Q35271194Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal models
Q69821212Zwitterionic detergent solubilisation of HSV-1 surface antigens

Search more.